Phathom Pharmaceuticals, Inc.
USD10.95
+0.08 (+0.74%)
CEO
Steven L. Basta
IPO Date
2019-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.01
Prev. Close
$10.87
Day Low
$10.82
Day High
$11.01
52W Low
$7.61
52W High
$18.31
Market Cap
$0.87B
Volume
0.03M
| -1.5 |
| 31 Dec 2023 | FY | 75.5% | -29558.9% | 277.1% | -48.7% | -1.91 | 10.25 | -2.3 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | 264.3% | -120.0% | -1.30 | 6.12 | -2.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -199.4% | -76.0% | 1.27 | 9.86 | -5.1 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -66.4% | -43.7% | 0.25 | 5.25 | -8.6 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -92.0% | -81.6% | 0.10 | 68.20 | -3.7 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 100.2% | -142.8% | -1.52 | 0.41 | -163.8 |
| -14.5 |
| 30 Sept 2025 | Q3 | 87.5% | -60.5% | 7.1% | -12.5% | -0.01 | 2.23 | -7.2 |
| 30 Jun 2025 | Q2 | 87.2% | -191.9% | 18.7% | -30.3% | -1.42 | 2.38 | -2.3 |
| 31 Mar 2025 | Q1 | 86.9% | -330.7% | 27.9% | -32.1% | -1.67 | 3.58 | -1.2 |
| 31 Dec 2024 | Q4 | 87.1% | -251.0% | 29.4% | -19.7% | -2.19 | 4.20 | -1.9 |
| 30 Sept 2024 | Q3 | 85.6% | -523.3% | 45.7% | -22.1% | -2.77 | 5.73 | -3.4 |
| 30 Jun 2024 | Q2 | 81.2% | -1248.6% | 39.1% | -28.6% | -2.17 | 6.48 | -1.7 |
| 31 Mar 2024 | Q1 | 77.7% | -4333.3% | 55.8% | -23.2% | -3.16 | 7.83 | -1.9 |
| 31 Dec 2023 | Q4 | 48.4% | -11667.0% | 109.4% | -19.2% | -1.91 | 10.25 | -1.6 |